New EULAR survey: Patients across Europe invited to share RMD experiences

FHS
June 14, 2024
2:26 pm

EULAR’s new survey seeks to gather valuable insights from patients across Europe on the impact of rheumatic and musculoskeletal diseases (RMDs).

NHS expedites availability of Belumosudil for chronic GVHD

Share this article The once-daily tablet hinders proteins that trigger the severe inflammatory response linked to chronic GVHD. Credit: fizkes / Shutterstock.com. The National Health

February 29, 2024

Early Data for GLP-1 Pill; FAERS Tirzepatide Reports; AI Diabetes Voice Screening

Studies presented at the European Association for the Study of Diabetes (EASD) annual meeting in Madrid included early data for oral amycretin, safety data for

September 14, 2024

Higher fluoride levels in pregnant women tied to children’s neurobehavioral problems

Higher fluoride levels in pregnant women are linked to increased odds of their children exhibiting neurobehavioral problems at age 3, according to a new study

May 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.